Acute Kidney Injury

<p>Acute Kidney Injury (AKI) Special Guest: Erin Barreto, PharmD, MSc, BCPS, BCCCP, FCCM</p> <p>Show Notes: <a href='https://pharmacytodose.files.wordpress.com/2020/02/aki-show-notes.pdf'>https://pharmacytodose.files.wordpress.com/2020/02/aki-show-notes.pdf</a></p> <p>Show References: <a href='https://pharmacytodose.files.wordpress.com/2020/02/aki-references.pdf'>https://pharmacytodose.files.wordpress.com/2020/02/aki-references.pdf</a></p> <p>1:10 – Show updates!; 9:15 – Define and classify AKI; 14:45 – Subspecifying the type of AKI; 18:22 – Prevalence of AKI in the ICU; 20:45 – Identification of high-risk patients; 24:43 – Preferred risk prediction tools; 26:12 – Ideal kidney biomarker; 28:28 – Ideal v. current biomarkers; 32:13 – Structural biomarkers; 39:40 – AKI prevention; 44:08 – Kidney/drug dosing equations; 53:49 – Equations in AKI/renal recovery; 56:43 – Cystatin C; 72:19 – What if you don’t use novel biomarkers?; 75:33 – Favorite calculator for AKI clinical risk predictor tool; 77:43 – AKI potpourri; 85:05 – Take-home points</p> <p>PharmacyToDose.Com @PharmacyToDose on Twitter/Instagram <a href='mailto:PharmacyToDose@Gmail.com'>PharmacyToDose@Gmail.com</a></p>